Adenocarcinoma with peritoneal metastases Cancer
Conditions
Interventions
4-8 patients are recruited from each of the three treatment groups:
1. Adjuvant chemotherapy
2. HIPEC (hyperthermic intraperitoneal chemotherapy)
3. PIP
Sponsors
Cwm Taf University Health Board
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients with disseminated peritoneal adenocarcinoma (of ovarian or colorectal origin) 2. Patients who are due to undergo treatment with; palliative chemotherapy OR HIPEC (Hyperthermic intraperitoneal chemotherapy) OR ePIPAC (electrostatic pressurised intra peritoneal aerosol chemotherapy) 3. Patients >18 years of age 4. Patients who are able to give informed consent
Exclusion criteria
Exclusion criteria: Unable to give informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Patient’s perspective and attitudes to the treatment option, assessed using qualitative interviews and focus groups at baseline and 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Quality of life, measured using EQ5D 2. Personality profile of the patient and attitude of risk, assessed using Ten Item Personality inventory 3. Side effects experienced, assessed using patient diary and qualitative interviews Measured at baseline and 3 months, with the patient diary also being assessed at 6 weeks | — |
Countries
United Kingdom
Outcome results
None listed